A previous study in mice found that GPHB5 overexpression improved diet-induced obesity, reduced the levels of blood glucose, triglycerides, cholesterol and insulin, and increased the levels of T3 and T4 (17), suggesting that it is involved in the process of energy equilibrium in vivo. The gene discussed is GPHB5; the disease is obesity due to melanocortin 4 receptor deficiency.